TB PRACTECAL: launch event
Read: All MSF updates on COVID-19
Read more
In Nukus, Karakalpakstan, in the west of Uzbekistan, we treat patients for tuberculosis (TB) under the PRACTECAL clinical trial.

The trial combines the first new TB drugs available in over 50 years with existing drugs to treat drug-resistant forms of the disease. Uzbekistan is among the top 27 countries with the highest rates of multidrug-resistant TB (MDR-TB).

We also treat children with TB with a shorter regimen of nine months, instead of the usual 12 months or more, and is conducting research into the results.

In the capital, Tashkent, we support the regional AIDS centre, with the aim of increasing access to diagnosis and care for patients living with HIV and treating co-infections.

We are currently responding to the coronavirus COVID-19 pandemic in the country.

In 2018
 
Uzbekistan

You can see tuberculosis in Uzbekistan in a heartbeat

Project Update 24 Sep 2010
 
Uzbekistan

MSF assists victims of violence in Kyrgyzstan and Uzbekistan

Project Update 16 Jun 2010
 
Uzbekistan

TB care in Uzbekistan

Project Update 24 Mar 2008
 
Uzbekistan

Pilot project to prove that disease can be treated in poor countries.

Press Release 29 Oct 2003
 
Uzbekistan

Time to prioritise tuberculosis laboratory services

Project Update 1 Oct 2003
 
Uzbekistan

Thin Girl with a Headscarf

Project Update 1 Aug 2003